Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and...

Descripción completa

Detalles Bibliográficos
Autores principales: Barco, Stefano, Bingisser, Roland, Colucci, Giuseppe, Frenk, André, Gerber, Bernhard, Held, Ulrike, Mach, Francois, Mazzolai, Lucia, Righini, Marc, Rosemann, Thomas, Sebastian, Tim, Spescha, Rebecca, Stortecky, Stefan, Windecker, Stephan, Kucher, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479300/
https://www.ncbi.nlm.nih.gov/pubmed/32907635
http://dx.doi.org/10.1186/s13063-020-04678-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479300/
https://www.ncbi.nlm.nih.gov/pubmed/32907635
http://dx.doi.org/10.1186/s13063-020-04678-4

Ejemplares similares